This plant is MN Pharmaceuticals' latest production facility, that is completed in October 2003 and is one of the most "state of the art" production facilities in Turkey.
The plant is dedicated to non-penicillin and non-cephalosporin finished dosage forms. It has seven floors, each encompassing a base area of 3200 square meters.
The following pharmaceutical manufacturing activities are licensed by the Turkish Health Authorities for Plant III - Other Products.
| Liquid ampoules for injection | 10,6 million ampoules (5 ml) | ||||||||||||||||||
| Liquid vials for injection | 16,4 million vials (5 ml) | ||||||||||||||||||
| Freeze-dried ampoules | 9,6 million ampoules (5 ml) | ||||||||||||||||||
| Freeze-dried vials | 11,1 million vials (5 ml) | ||||||||||||||||||
| Dry powder for suspension | 2,1 million bottles (100 ml pp) | ||||||||||||||||||
| Tablets | 235 million tablets | ||||||||||||||||||
| Wet granulation | 37 tons | ||||||||||||||||||
| Fluid bed granulation | 20 tons | ||||||||||||||||||
| Film-coated tablets (coating capacity) | 24 tons | ||||||||||||||||||
| Hard gelatine capsules | 70 million capsules | ||||||||||||||||||